Bruker Overview

  • Year Founded
  • 1960

Year Founded

  • Status
  • Public

  • Employees
  • 8,525

Employees

  • Stock Symbol
  • BRKR

Stock Symbol

  • Investments
  • 84

  • Share Price
  • $67.97
  • (As of Friday Closing)

Bruker General Information

Description

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.

Contact Information

Website
www.bruker.com
Formerly Known As
Bruker BioSciences
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Primary Office
  • 40 Manning Road
  • Billerica, MA 01821
  • United States
+1 (978) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bruker Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$67.97 $68.80 $53.79 - $84.84 $9.5B 138M 840K $2.17

Bruker Financials Summary

In Thousands,
USD 		TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 9,848,948 10,597,404 12,896,890 8,553,242
Revenue 2,818,400 2,530,700 2,417,900 1,987,500
EBITDA 535,000 514,700 496,100 317,400
Net Income 319,100 296,600 277,100 157,800
Total Assets 3,819,600 3,611,800 3,650,000 3,049,000
Total Debt 1,219,600 1,270,400 1,393,900 912,800
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bruker Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Bruker‘s full profile, request access.

Request a free trial

Bruker Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical,
Diagnostic Equipment
Billerica, MA
8,525 As of 2022
00.000
000000000 00 00.000

000000

orem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor in
0000000000 000000000
Waltham, MA
00000 As of 0000
00.000
000000000 00.000

00000-

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000000000 000000000
Raritan, NJ
0000 As of 0000
00.00
00 0000-00-00
000000&0 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bruker Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Revvity Corporation Waltham, MA 00000 00.000 000000000 00.000
00000-00000000 000 Formerly PE-Backed Raritan, NJ 0000 00.00 000000&0 00.00
000-000 0000000000 Corporation Hercules, CA 0000 00.000 000000000 00.000
0000é00000 Corporation Marcy l'Etoile, France 00000 00000 000000000 00000
000000000 Corporate Backed or Acquired Goettingen, Germany 00000 000000&0
You’re viewing 5 of 8 competitors. Get the full list »

Bruker Patents

  • 4,657

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3,237

    Granted

  • 164

    Pending

  • 000

    Expiring in next 12 mo

Bruker Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102022123559-B3 Method and device for monitoring and controlling the performance of an ion source Active 15-Sep-2022 00
GB-202300045-D0 Method for determining an element concentration of an eds/wds spectrum of an unknow sample and a corresponding device Pending 21-Mar-2022 000000000
GB-2616939-A Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device Pending 21-Mar-2022 000000000
EP-4249902-A1 Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device Pending 21-Mar-2022 000000000 0
US-20230358695-A1 Method for determining an element concentration of an eds/wds spectrum of an unknown sample and a corresponding device Pending 21-Mar-2022 G01N23/2209
To view Bruker’s complete patent history, request access »

Bruker Executive Team (28)

Name Title Board Seat Contact Info
Frank Laukien Ph.D Chief Executive Officer, President & Chairman
Thomas Schuelein President & Managing Director
Mark Munch Ph.D Executive Vice President & President
Rohan Thakur Ph.D President & Executive Vice President
Juergen Srega President
You’re viewing 5 of 28 executive team members. Get the full list »

Bruker Board Members (11)

Name Representing Role Since
Adelene Perkins Self Board Member 000 0000
Bonnie Anderson Self Board Member 000 0000
Cynthia Friend Ph.D Bruker Board Member 000 0000
Frank Laukien Ph.D Bruker Chief Executive Officer, President & Chairman 000 0000
Hermann Requardt Ph.D Bruker Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Bruker Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bruker Investments & Acquisitions (84)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MIRO (Electronic Equipment and Instruments) 03-Oct-2023 0000000000 Electronic Equipment and Instruments
PhenomeX 03-Oct-2023 0000000000 00000 Drug Discovery 0000 0000
Interherence 03-Jul-2023 0000000000 000.00 Monitoring Equipment
Kiyatec 18-May-2023 00000 0000 0000 Decision/Risk Analysis
Zontal 04-May-2023 Merger/Acquisition IT Consulting and Outsourcing 00000 000
You’re viewing 5 of 84 investments and acquisitions. Get the full list »

Bruker Subsidiaries (24)

Company Name Industry Location Founded
Interherence Monitoring Equipment Erlangen, Germany 2019
MIRO (Electronic Equipment and Instruments) Electronic Equipment and Instruments Zurich, Switzerland 0000
Canopy Biosciences Discovery Tools (Healthcare) Saint Louis, MO 0000
Zontal IT Consulting and Outsourcing Plantation, FL 0000
Molecubes Other Healthcare Technology Systems Gent, Belgium 0000
You’re viewing 5 of 24 subsidiaries. Get the full list »

Bruker ESG

Risk Overview

Risk Rating

Updated September, 14, 2022

20.71 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,708

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 884

Rank

00.00

Percentile

Laboratory Equipment and Services

Subindustry

00 of 67

Rank

00.0

Percentile

To view Bruker’s complete esg history, request access »

Bruker Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
Haystack Oncology 16-Nov-2022 00000 00000 00 0000 Completed
  • 4 buyers
Bruker (ICP-MS Business) 19-May-2010 000000000000000000 Completed
  • 000000
Spectral Solutions 01-Jun-2007 000000000000000000 Completed
  • 000000
VACUUMSCHMELZE 01-Jun-2003 000000000000000000 Completed
  • 000000
GeneFormatics 01-Oct-2001 Early Stage VC 0000 Completed
  • 11 buyers
To view Bruker’s complete exits history, request access »